Dose-intensive use of cyclophosphamide in ablation of neuroblastoma-Reference-Cited by-同舟云学术

Dose-intensive use of cyclophosphamide in ablation of neuroblastoma

Published:1990-09-15 Issue:6 Volume:66 Page:1095-1100
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kushner Brian H.,O'Reilly Richard J.,Laquaglia Michael,Cheung Nai-Kong V.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference38 articles.

1. Staging systems in neuroblastoma. In: ed. Pediatric Hematology/Oncology Reviews. New York: Praeger, 1985; 130–137.

2. Association of Multiple Copies of the N-mycOncogene with Rapid Progression of Neuroblastomas

3. Prognostic factors in neuroblastoma

4. , et al. Therapeutic efficacy of single drugs for childhood neuroblastoma: A review. In: , et al., eds. Pediatric Oncology. Amsterdam: Excerpta Medica, 1982; 141–150.

5. Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stage 4N neuroblastoma before and during the era of anti‐G_D2 immunotherapy;International Journal of Cancer;2023-08-21

2. Cyclophosphamide has Long-Term Effects on Proliferation in Olfactory Epithelia;Chemical Senses;2019-12-17

3. Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin;Oncotarget;2015-11-26

4. A 20-Year-Old Male with Back Pain;Pediatric Annals;2010-10

5. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: Broad implications for immunotherapy;Pediatric Blood & Cancer;2007-04